Occupational and environmental settings present opportunities for humans to come into contact with a variety of chemicals via the dermal route. The chemicals contacting the skin are likely to be diluted with a vehicle or present as a component of a mixture. In order to support risk assessment activities, we evaluated the vehicle effects on dermal penetration of two halogenated hydrocarbons, dibromomethane (DBM) and bromochloromethane (BCM). In vivo exposures to 15 combinations of of these in water, mineral oil, and corn oil vehicles were conducted, and blood was sampled for dibromomethane and bromochloromethane during the exposure at 0.5, 1, 2, 4, 8, 12, and 24 h. A physiologically based pharmacokinetic (PBPK) model was used to estimate the total amounts of dibromomethane or bromochloromethane that were absorbed during the exposure, and the dermal permeability coefficients were determined. While the permeability coefficients for dibromomethane and bromochloromethane were approximately 73-and 40-fold higher, respectively, in the water vehicle than in the corn oil, the permeability coefficient, when normalized for the skin:vehicle matrix partition coefficient, varied by less than a factor of 2. The permeability in an aqueous vehicle was then successfully used to predict the permeability coefficient for dibromomethane in a nonpolar vehicle, peanut oil.
Humans can come into contact with a variety of chemicals via the dermal route in occupational and environmental settings. Chemicals belonging to the class of halogenated carbons have historically been well represented in the workplace as solvents and degreasers, and in the environment as contaminants from industrial and military operations. Human health risk assessment for dermal exposures requires a method for estimating the amount of chemical that gains access to the systemic circulation (Surber et al., 1990) . This is true for pharmaceutical efficacy determinations and for safety assessments of cosmetics that occur in a range of formulations (Brain et al., 1995; Bronaugh et al., 1981; Dick et al., 1997a; Heylings et al., 1996) and for risk assessments of chemicals of occupational interest (Blank and McAuliffe, 1985) . The potential for these chemical exposures to cause beneficial or adverse systemic effects depends on the capacity of the chemical to cross the dermal barrier, enter the systemic blood circulation, and elicit a response.
In order for a chemical to gain access to the systemic blood circulation, it must first overcome the barrier function of the skin, primarily performed by the densely packed, lipid-protein stratum corneum (Ritschel and Hussain, 1988) . This is the outermost layer of the skin, and it represents a passive barrier to the diffusion of most chemicals, but the stratum corneum is not an equally effective barrier for all chemicals. Reviews have been published that discuss the anatomical and physicochemical properties believed responsible for chemical movement across skin (Guy and Hadgraft, 1988; Ritschel and Hussain, 1988; Stoughton, 1989) . Additionally, quantitative approaches have been developed to describe chemical movement across skin. The descriptor that is often used for transdermal movement by chemicals is the permeability coefficient, P (distance/ time), which is a composite term stemming from Fick's Law (Equation 1).
In Equation 1, J is the flux (mass/area/time), Km is the skin: vehicle partition coefficient, D is the diffusion coefficient (distance 2 /time), L is the diffusion pathlength, and Co and Ci are the chemical concentrations outside and inside the barrier, respectively (mass/volume).
The physiologically based pharmacokinetic (PBPK) model is a useful tool for evaluating the dermal permeability coefficient. The model and process have been previously described in detail (Jepson and McDougal, 1997; McDougal et al., 1990; McDougal et al., 1986) . Briefly, the PBPK model can be used to estimate the total amount of chemical absorbed during the exposure. It does this by maintaining a mass balance for the chemical as it distributes in or is eliminated from the body. In turn, the cumulative amount of chemical absorbed (ABS) can be directly combined with the exposure time (t) and surface area (A) to define the average flux (J) of chemical across the dermal barrier (Equation 2).
Permeability coefficients determined for a neat (undiluted) chemical can be used to evaluate the ability of the chemical to migrate across the skin and enter the blood system. However, chemical exposures that occur in occupational and environmental settings are likely to consist of mixtures or to be combined with a diluent (vehicle). Vehicles can greatly influence the rate and extent to which a chemical gains access to the systemic blood circulation during a dermal exposure. Vehicles in the form of ointments, creams, and drug delivery matrices have been used to control the dermal delivery of pharmaceutical agents (Dick et al., 1997b; Mollgaard and Hoelgaard, 1983; Patel and Vasavada, 1988) . Furthermore, chemical vehicles contained in product formulations or as part of chemical mixtures can potentially produce significant impact on dermal penetration rates of chemicals contacted in occupational or environmental settings (Blank and McAuliffe, 1985; Brain et al., 1995; Bronaugh et al., 1981; Stoughton, 1989) . Vehicleinduced permeability coefficient changes spanning 100-fold or more have been reported (Blank and McAuliffe, 1985; Bronaugh et al., 1981) . Therefore, it is essential to use a permeability constant for absorption from the vehicle that is present in the exposure, in order to adequately evaluate the dermal absorption kinetics and subsequent human health risks associated with the exposures to chemicals in vehicles or matrices.
The influence of the matrix in which a chemical resides at the time of the exposure creates both complexity and opportunity. The complexity arises from the interaction between the chemical of interest, the dermal barrier, and the diluent (vehicle). The opportunity arises from the fact that vehicles can be used to alter dermal absorption in order to meet specific objectives. Dermal drug delivery, for example, can be altered by using appropriate vehicles in order to deliver the necessary amount of therapeutic agent at the desired rate (Ritschel and Hussain, 1988) .
The purpose of this study was to quantitatively understand the in vivo dermal absorption kinetics of two halogenated hydrocarbons, dibromomethane (DBM) and bromochloromethane (BCM), in the presence of vehicles, both polar (water) and nonpolar (corn oil). The study was designed to determine if a knowledge of (1) chemical partitioning between a given skin and vehicle, and (2) the measured permeability in that vehicle could be used to predict the permeability of the chemical residing in a dissimilar vehicle. This approach would 'normalize' the permeability coefficient for a chemical and allow for rapid calculation of the permeability coefficient from a given vehicle without the need for additional in-vivo dermal exposures.
MATERIALS AND METHODS
Laboratory animals. The animal use described in this study was conducted in accordance with the principles stated in the 'Guide for the Care and Use of Laboratory Animals ', National Research Council, 1996 , and the Animal Welfare Act of 1966, as amended.
Male Fischer-344 rats weighing 200 -250 grams, purchased from Charles River Breeders, were provided free access to food (Purina Rat Chow) and deionized water while being maintained in a 12-h light/dark cycle (6:00 A.M. to 6:00 P.M.). Rats were individually housed in plastic 24 ϫ 45 ϫ 20 cm cages with a 1.5 cm thick layer of cedar bedding. Jugular cannulation and cell attachment. On the day before the exposure, the animals were anesthetized with a 1 ml/kg body weight ip injection of a solution containing 70 mg/ml Ketamine (Ketaset, Ketamine Hydrochloride, Parke-Davis, Morris Plains, NJ) and 6 mg/ml Xylazine (Rompun injectable, Miles Laboratories, Shawnee Mission, KS). The fur on the back of each rat was closely clipped with a #40 blade in order to expose the dermal cells.
Each rat was surgically implanted with a jugular cannula to facilitate blood-sample drawing during the exposure period. The cannulae were made of silastic medical-grade tubing (Dow Corning, Midland, MI) and had an internal diameter of 0.02 inches. Each cannula was 10.5 inches long with a 3-mmdiameter bulb made of silastic adhesive (Silicone Medical Adhesive, Dow Corning, Midland, MI) placed approximately 5 cm from the tip and used for attachment of the cannula to the animal. The bulb was used to improve stability and patency of the jugular cannula. After surgery, the cannula was filled with a 25% heparin (Heparin Sodium Injection, SoloPak Laboratories, Franklin Park, IL) in normal saline solution and then capped. The cannula was exteriorized at the back of the neck for easy access, and the animals were fitted with velcro harnesses to protect the cannula and a 3.14 cm 2 glass dermal exposure cell that had been attached with cyanoacrylate adhesive (Pacer Technology, Rancho Cucamonga, CA) to the area of the mid-back approximately 100 mm from an imaginary line drawn between the rat's ears, where the fur was closely clipped. The cell had been fitted with a Teflon septum and sealed with a crimp top cap prior to dermal attachment.
Partition coefficients.
Physiologically based pharmacokinetic models rely on partition coefficients to describe the distribution of chemical in biological tissues. The number and type of partition coefficients needed depends on the chemical and system being evaluated. The model used in this work requires the input of five types of partition coefficient (Km) values for DBM and BCM: (1) vehicle:air, (2) neat (undiluted) DBM or BCM:whole skin, (3) stratum corneum:air, (4) skin:DBM or :BCM vehicle matrix, and (5) biological tissue:air partition coefficients. The biological tissue:air partition coefficients were available in the literature but the others were determined experimentally.
Vehicle:air partition coefficients for dibromomethane and bromochloromethane in the corn oil, mineral oil, peanut oil, and water vehicles were determined using the vial-equilibration method (Sato and Nakajima, 1978) as modified by Gargas et al., 1989 (Equation 3 ),
where A h,r is the area count in the headspace of the reference vial, V h,r is the volume of the headspace in the reference vial, V s is the volume of sample, and A h,s is the area count in the headspace of the sample vial. The partition coefficients for the neat (undiluted) dibromomethane to skin were determined by incubating skin samples in neat liquid, removing excess chemical, and extracting the absorbed chemical in an organic solvent. Skin samples were obtained by euthanizing rats via CO 2 inhalation and shaving the fur on the back of the rat. A 2 cm ϫ 2 cm area of skin was excised and cleaned of fat and connective tissue. Skin samples weighing approximately 20 mg were obtained using a small skin punch, and placed into pre-weighed vials. One ml of neat dibromomethane was added to the skin sample and incubated at 32°C for 2 h. After incubation, the sample was removed, dried with a gauze pad, and placed into a vial containing 4.0 ml of n-hexane. The skin sample was then extracted into the n-hexane by shaking on a vortex evaporator for 1 h. The extraction efficiency was 97.5% as determined by serial extraction of DBM or BCM from the skin sample. The n-hexane layer was analyzed for dibromomethane by injecting one uL of sample via autoinjector into a HewlettPackard 5890 series II gas chromatograph equipped with an electron-capture detector as described in the chromatographic analysis section. The neat liquid to skin partition coefficient was taken as the ratio of the chemical concentration in the neat liquid to the chemical concentration in the skin.
Stratum corneum:air partition coefficients for dibromomethane and bromochloromethane were determined using a modification of the thermogravimetric analysis approach described by Liron, et al., 1994 . Briefly, 5-mg stratum corneum samples were placed into a DBM or BCM vapor stream until the weight of the sample reached a steady-state. The amount of DBM or BCM that had been taken up was used to calculate the concentration of DBM or BCM in the stratum corneum. The stratum corneum:air partition coefficient was calculated as the ratio of the DBM or BCM concentration in stratum corneum and DBM or BCM concentration in the vapor stream.
When the chemical concentration in the vehicle is very low (e.g., 0.1%), it is likely that the skin:vehicle and the skin:vehicle-chemical matrix partition coefficients will be the same, and the skin:vehicle partition coefficient values can be applied. In situations where the skin:vehicle and skin:vehicle-chemical matrix are different, the skin:vehicle partition coefficient value would be inappropriate for use in phamacokinetic descriptions and an alternative approach would be required. Since the partitioning characteristics are different for individual chemical/oil vehicle combinations, Equation 4 was used to determine skin:vehicle-chemical matrix partition coefficients (Km) for each of the oil vehicle matrices.
In Equation 4, X c is the fraction of the matrix that is the chemical of interest, X v is the fraction of the matrix that is the vehicle, K m,s/c is the skin:chemical partition coefficient and K m,s/v is the skin:vehicle partition coefficient.
In vivo chemical/vehicle exposures. The day following the surgery and dermal exposure cell attachment, a group of 20 -25 animals was separated into three or four groups. Each group received a different concentration of a test chemical in a specific vehicle. The process was repeated until all of the chemical and vehicle combinations of interest were completed. The chemical/ vehicle combinations selected for this work were dibromomethane (DBM, Aldrich Chemical Co., 99%) and bromochloromethane (BCM, Aldrich Chemical Co., 99%) in corn oil, peanut oil, mineral oil, or water. The dibromomethane concentrations (wt/vol) corresponding to 25%, 50%, and 75% in mineral oil, peanut oil and corn oil, respectively, were 619.5, 1239, and 1858.5 mg/ml and bromochloromethane concentrations were 497.7, 995.3, and 1493 mg/ml. The dibromomethane and bromochloromethane concentrations in water were 25% saturated, 50% saturated, 75% saturated and 100% saturated at 25°C. These saturation levels in water corresponded to dibromomethane concentrations of 2.4, 6.14, 7.6, and 9.4 mg/ml, respectively. For bromochloromethane, the stated saturation levels in water corresponded to concentrations of 3.6, 6.6, 9.3, and 12.8 mg/ml, respectively.
The exposure was initiated by adding 3.0 ml of the chemical/vehicle mixture to the dermal exposure cell. The solution was injected into the exposure cell by penetrating its septum with a 20-gauge needle attached to a glass tuberculin syringe. A 23-gauge needle was inserted through the septum prior to and during addition of the chemical/vehicle solution in order to vent pressure build up.
Blood samples were drawn immediately prior to addition of chemical to the dermal exposure cell and at 0.5, 1, 2, 4, 8, 12, and 24 h after addition of the chemical or chemical/vehicle solution. Each blood sample had a volume of 0.1 ml and was collected through the cannula into a 0.25-ml glass tuberculin syringe. A 25-gauge stainless steel needle was attached to the glass syringe and the blood was injected into a 2.0 ml septum sealed vial containing 1.0 ml of n-hexane (from Baxter, Burdick and Jackson, 99.9ϩ%). The cannula was filled with a 25% heparin in normal saline solution after each blood drawing. Immediately prior to each drawing, the heparin solution in the cannula was removed and discarded. The dibromomethane or bromochloromethane was extracted from the blood into the n-hexane by shaking the samples vigorously on a vortex evaporator (Haake-Buchler, Labconco Corp., Kansas City, MO, Model 4322000) for 15 min. After shaking, 500 uL of the n-hexane was removed and placed into a 2.0-ml autosampler vial and sealed with a Teflon crimp. The n-hexane layer was analyzed for dibromomethane or bromochloromethane by injecting one uL of sample via autoinjector into a HewlettPackard 5890 series II gas chromatograph equipped with an electron-capture detector as described in the chromatographic analysis section.
Chromatographic analysis of DBM and BCM. Analysis for dibromomethane or bromochloromethane was accomplished by injecting a sample into a Hewlett-Packard 5890 series II gas chromatograph equipped with an electron-capture detector. The samples were introduced into a 30-meter-long, 530-m diameter, DB-1 wide-bore gas chromatography column with a film thickness of 3.0 m. The carrier gas was an ultrapure blend in the ratio of 95% argon to 5% methane. Standard curves were done with dibromomethane or bromochloromethane in n-hexane and treated as samples drawn from the laboratory animals. Analytical linearity was achieved at chemical concentrations of 0.05 g/ml and greater. The conditions specific for dibromomethane were a column carrier flow of 6.85 ml/min with an isothermal oven temperature of 80°C. The resulting column-retention time was 3.1 min. The injector and detector temperatures were 125 and 300°C, respectively. The conditions specific for bromochloromethane were a column flow of 7.15 ml/min with an isothermal oven temperature of 60°C. The resulting column retention time was 2.9 min. All other gas chromatography conditions were the same as described above for DBM.
Physiologically based pharmacokinetic (PBPK) model. The physiologically based model and physiological parameters used in this study are the same as those described by Jepson and McDougal (1997) , except for the partitioning values associated with the vehicles. Briefly, the model was composed of physiological compartments for skin, lung, liver, fat, muscle, rapidly perfused tissue, and slowly perfused tissue. The skin compartment included a dermal exposure cell used to place the chemical and vehicle in contact with the skin. The values for physiological parameters relating to organ volumes, blood flows, ventilation rate, and cardiac output are specific for the biological species of interest. The physiological values used in the case of the Fischer-344 rat have previously been reported and used in quantitative descriptions of biological systems (Ramsey and Andersen, 1984) . The metabolic constants that are scaled to body weight in the model are the maximum rate of metabolism (VMAXC) and the first order metabolism rate (KFC). The chemical-specific, tissue-to-blood partition coefficient and metabolism values were extracted from the literature (Gargas, et al., 1986 (Gargas, et al., , 1989 and used in the PBPK model (Table 1) . The model code was written in Advanced Continuous Simulation Language (ACSL, Mitchell and Gauthier Associates, Inc., Concord, MA) which is imbedded in an optimization software package marketed as Simusolv (The Dow Chemical Company, Midland, MI).
RESULTS

Corn Oil Vehicle
Peak dibromomethane concentrations in blood during a 24-h, corn-oil vehicle, closed-dermal-cell exposure ranged from 18.1 g/ml (104 M) in the 25% solution to 128.8 g/ml (740 M) in the 75% solution. The peak blood concentrations occurred at approximately 8 h and remained relatively constant throughout the rest of the exposure (Fig. 1) . Peak bromochloromethane concentrations in blood during a 24-h, corn-oil vehicle, closed-dermal-cell exposure ranged from 28.0 g/ml (216 M) in the 25% solution to 87.7 g/ml (678 M) in the 75% solution. The blood concentration peaked at about five h and remained relatively constant throughout the exposure (Fig. 2) .
Mineral Oil Vehicle
Peak dibromomethane concentrations in blood during a 24-h, mineral-oil vehicle, closed-dermal-cell exposure ranged from 48.5 g/ml (279 M) in the 25% solution to 162.4 g/ml (934 M) in the 75% solution. The maximum blood levels were achieved at approximately 8 h in the 25% exposure and 12 h or more in the 50% and 75% exposures. dibromomethane in mineral oil produced data with greater variability than data generated from other vehicles (Fig. 3) . Peak bromochloromethane concentrations in blood during a 24-h, mineral-oil vehicle, closed-dermal-cell exposure ranged from 45.5 g/ml (352 M) in the 25% solution to 130.8 g/ml (1.0 mM) in the 75% solution. The peak blood concentration was achieved between 4 and 8 h and then declined (Fig. 4) .
Water Vehicle
Peak dibromomethane concentrations in blood during a 24-h, water-vehicle, closed-dermal-cell exposure ranged from 1.0 g/ml (5.8 M) in the 25% saturated solution to 5.9 g/ml (33.7 M) in the saturated solution. The peak concentrations of dibromomethane in blood occurred at approximately 2 h and then declined toward baseline. The declining blood levels of dibromomethane in the water-vehicle exposures reflected a decline in the measured dibromomethane-exposure concentration as the chemical was absorbed (Fig. 5) . Peak bromochloromethane concentrations in blood during a 24-h, water-vehicle, closed-dermal-cell exposure ranged from 0.8 g/ml (6.3 M) in the 25% saturated solution to 8.9 g/ml (69.1 M) in the 100% saturated solution. The blood concentrations peaked at about 2 h and then declined to near zero (Fig. 6) . The relatively low-achievable exposure chemical concentration, as Gargas et al., 1986 Gargas et al., , 1989 .
FIG. 1.
Dibromomethane (DBM) concentrations in blood following dermal doses of DBM in corn oil. Blood concentrations are reported as the mean Ϯ SD (n, 5-10). Dibromomethane concentrations in corn oil were 619.5 mg/ml, 1239.0 mg/ml, and 1858.5 mg/ml for the 25, 50, and 75% solutions, respectively.
FIG. 2. Bromochloromethane (BCM) Concentrations in blood following
dermal doses of BCM in corn oil. Blood concentrations are reported as the mean Ϯ SD (n, 5-10). Bromochloromethane concentrations in corn oil were 497.7 mg/ml, 995.3 mg/ml, and 1493 mg/ml for the 25, 50, and 75% solutions, respectively.
FIG. 3. Dibromomethane (DBM)
Concentrations in blood following dermal doses of DBM in mineral oil. Blood concentrations are reported as the mean Ϯ SD (n, 5-10). Dibromomethane concentrations in mineral oil were 619.5 mg/ml, 1239.0 mg/ml and 1858.5 mg/ml for the 25, 50 and 75% solutions, respectively.
FIG. 4. Bromochloromethane (BCM) Concentrations in blood following
dermal doses of BCM in mineral oil. Blood concentrations are reported as the mean Ϯ SD (n, 5-10). Bromochloromethane concentrations in mineral oil were 497.7 mg/ml, 995.3 mg/ml, and 1493 mg/ml for the 25, 50, and 75% solutions, respectively.
FIG. 5. Dibromomethane (DBM)
Concentrations in blood following dermal doses of DBM in water. Blood concentrations are reported as the mean Ϯ SD (n, 5-10). Dibromomethane concentrations in water were 2.42, 6.14, 7.55, and 9.36 mg/ml for the 25, 50, and 75%, and saturated solutions, respectively.
FIG. 6. Bromochloromethane (BCM) Concentrations in blood following
dermal doses of BCM in water. Blood concentrations are reported as the mean Ϯ SD (n, 5-10). Bromochloromethane concentrations in water were 3.6, 6.6, 9.3, and 12.8 g/ml for the 25, 50, and 75%, and saturated solutions, respectively. compared to the oil vehicles, was due to the low solubility of bromochloromethane in water.
Permeability Coefficients
The chemical concentration in blood was evaluated using a PBPK model and used to estimate the total amount of chemical absorbed during the dermal exposure. Permeability coefficients were optimized for each of the dibromomethane and bromochloromethane exposures in each of the vehicles. The dibromomethane permeability coefficients spanned nearly two orders of magnitude ranging from 0.003 cm/h in the neat dibromomethane to 0.22 cm/h for dibromomethane in water. The bromochloromethane permeability coefficients similarly ranged from 0.003 cm/h in a 75% bromochloromethane/corn oil solution to 0.17 cm/h for bromochloromethane in water (Table 2) . Even though the permeability coefficients were up to 73 times greater in the water vehicles than in the corn-oil or mineral-oil exposures, the normalized permeability coefficient for each chemical was relatively constant across the wide range of exposure matrices ( Table 2 ). The skin:vehicle partition coefficient values used to calculate the normalized permeability coefficient represented the composition of the chemical: vehicle matrix and therefore were not identical for each vehicle type. This represents the partitioning contribution of both the chemical and the vehicle of interest (Tables 2 and 4 ). The mean normalized permeability coefficient was 0.0277 cm/h with a standard deviation of 0.0041 cm/h and 0.0264 cm/h with a standard deviation of 0.0074 for bromochloromethane and dibromomethane, respectively (Table 3) .
Application of the Normalized Permeability Coefficient
The peanut oil:air partition coefficient for dibromomethane was 866. This value was between the extremes represented by the water:air, 14.4, and the corn oil:air, 1023, partition coefficients for dibromomethane. Using the vehicle:matrix partition coefficient and the normalized permeability coefficient (Table  3) , P values were predicted for dermal exposures to 25%, 50%, and 75% dibromomethane in peanut oil vehicle using a PBPK model. In order to test the model predictions, dermal exposures to dibromomethane in peanut oil (Figs. 7-9) were conducted and the resulting permeability coefficients and blood levels of dibromomethane were compared to the predicted values (Table 4).
DISCUSSION
In this study, dermal permeability coefficients as estimated by PBPK modeling for dibromomethane and bromochloromethane varied by as much as 67-fold depending on the vehicles selected. In the thermodynamically unfavorable aqueous environment, the observed dermal permeability coefficient for dibromomethane was much higher (0.22 cm/h) when compared to the corn oil environment (0.0033 cm/h). Similar results were observed with bromochloromethane in water and oil vehicles. The vehicle effects observed were consistent with observations published for occupational and cosmetic chemicals delivered in vehicles. Blank and McAuliffe (1985) observed that the permeability coefficient for benzene varied 100-fold between the water and hexadecane vehicles. An even more pronounced vehicle effect was observed by Bronaugh et al. (1981) who reported a 250-fold difference in the permeability coefficient for N-nitrosodiethanolamine applied in water as compared to application in isoproppyl myristate. In this study, fifteen combinations of bromochloromethane or dibromomethane in water, corn oil, or mineral oil were prepared, each with different partitioning characteristics and dermal permeability coefficients. Yet, the permeability coefficient for each chemical was relatively constant when normalized for the vehicle matrix:skin partition coefficient. Based on this observation, normalized permeability coefficients can be used to predict the dermal permeability of bromochloromethane or dibromomethane when applied in water or oil vehicles. The basis for this utility is that the permeability coefficient (P) is proportional to partitioning (Km) and diffusion (D) as in Equation 5.
If diffusion is assumed to be constant once the chemical enters the skin, it can be seen from Equation 5 that the permeability coefficient is directly proportional to the skin:vehicle partition coefficient. Using the permeability coefficient definition in Equation 1 and the assumptions made in Equation 5, the relationship between the permeability and partition coefficients can be used to define the normalized permeability coefficient
For a given biological species and chemical, D/L is constant and equivalent to the P n. Based on Equation 6, the permeability coefficient for a chemical residing in one vehicle can be predicted using the normalized permeability coefficient and the skin:vehicle partition coefficient as shown in Equation 7.
FIG. 7. Simulation vs. measured blood concentration of dibromomethane (DBM) using predicted permeability coefficient, P, for a dermal dose of 25% DBM in peanut oil. Mean blood concentrations are shown as solid circles Ϯ SD with the simulation shown as a line. The dibromomethane concentration in mineral oil was 619.5 mg/ml (25% solution).
FIG. 8.
Simulation vs. measured blood concentration of dibromomethane (DBM) using predicted permeability coefficient, P, for a dermal dose of 50% DBM in peanut oil. Mean blood concentrations are shown as solid circles Ϯ SD with the simulation shown as a line. The dibromomethane concentration in mineral oil was 1239.0 mg/ml (50% solution).
FIG. 9.
Simulation vs. measured blood concentration of dibromomethane (DBM) using predicted permeability coefficient, P, for a dermal dose of 75% DBM in peanut oil. Mean blood concentrations are shown as solid circles Ϯ SD with the simulation shown as a line. The dibromomethane concentration in mineral oil was 1858.5 mg/ml (75% solution).
The relationships in Equations 6 and 7 provide insight into the appropriateness of generalizations about correlations between partition and dermal permeability coefficients. Given the same diffusion pathlength, dermal permeability coefficients would be expected to correlate with skin:vehicle partition coefficients if the diffusion coefficient was the same for the chemicals being considered.
In addition to thermodynamic considerations that underlay the utility of the normalized permeability coefficient, the interaction of the vehicle with the dermal barrier can also be important. If chemicals or vehicles change the skin structure or composition, then the diffusion and partition characteristics may be altered. Such effects could dramatically change the permeability coefficient for dermal absorption of the chemical of interest. A notable example is the hydration state of the dermal barrier, and references to the generalized increase in dermal permeability with increasing hydration state have been made (Ritschel and Hussain, 1988; Scheuplein and Blank, 1973) . Surber et al. (1990) suggested that prolonged contact with water increased the uptake of a series of phenols into the stratum corneum. The reported increase in phenol uptake from an aqueous vehicle is likely due to the relatively good water solubility of phenol and the uptake of some water into the stratum corneum, as suggested by the authors. The rationale for this observation was that the phenol was able to travel with the water and gain access into the stratum corneum as it became hydrated. For the poorly-water-soluble, nonpolar chemicals used in this study, dibromomethane and bromochloromethane, hydration of the stratum corneum does not increase chemical uptake into the body via dermal exposure. Vehicles can also produce deviations in permeability behavior by binding to or residing in localized areas of the skin. In our study, the mineral-oil vehicle produced normalized dermal permeability coefficients that were slightly lower than those in the water and corn-oil vehicles for dibromomethane and bromochloromethane. This may due to the differences in mineral oil interaction with the skin or in the chemical differences between mineral oil and the other vehicles. Corn oil is composed of a variety of fatty acids (primarily oleic, linoleic, and palmitic) and mineral oil is a saturated hydrocarbon chain with the basic formula, C n H 2nϩ2 .
The observed dermal absorption kinetics of dibromomethane and bromochloromethane applied to the skin in water and oil vehicles highlight the importance of the chemical/vehicle matrix used for dosing. The dermal absorption properties of chemicals contacting the skin as part of a mixture depend largely on the partition coefficient between the skin and the entire mixture. The effect of matrix composition on the skin: vehicle partition coefficient is clearly shown in Tables 2 and 4 and should be considered when assessing the dermal absorption properties of chemicals present in mixtures such as those likely to occur in occupational or environmental settings.
This work demonstrates that physiologically based pharmacokinetic modeling can be used to interpret whole-animal dermal exposures to liquid organic chemicals, and to generate estimates of dermal permeability coefficients. Furthermore, the quantitative relationship between the permeability coefficient and the partition coefficient can be used to establish a normalized permeability coefficient which in turn can be used to predict the permeability coefficient for the chemical of interest in aqueous and oil vehicles. This capability can be particularly useful in human health risk-assessment applications, where the permeability coefficient can range by 100-fold for a single chemical, depending on its vehicle or solvent, when applied to the skin. 
